Time is brain: Is MRI the clock?

Current Opinion in Neurology

Volumn 20, Issue 4, 2007, Pages 410-416

  Neumann Haefelin, Tobias ^a   Steinmetz, Helmuth ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Hemorrhagic transformation; Ischemic stroke; Magnetic resonance imaging; Mismatch; Thrombolysis

Indexed keywords

DESMOTEPLASE;

BLOOD BRAIN BARRIER; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT TOOL; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; HUMAN; LEUKOARAIOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; POSITRON EMISSION TOMOGRAPHY; REVASCULARIZATION; REVIEW; RISK FACTOR; TISSUE INJURY;

BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; DIFFUSION; HUMANS; LEUKOARAIOSIS; MAGNETIC RESONANCE IMAGING; PERFUSION; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 34447307920     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e328186467d     Document Type: Review

References (42)

1. Chalela JA, Kidwell CS, Nentwich LM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 2007; 369:293-298. This large single center study provides clear evidence of the superior accuracy of MRI compared with CT for the assessment of acute stroke patients.
2. Heiss WD, Sobesky J, Hesselmann V. Identifying thresholds for penumbra and irreversible tissue damage. Stroke 2004; 35:2671-2674.
3. Sobesky J, Zaro Weber O, Lehnhardt FG, et al. Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke. Stroke 2005; 36:980-985.
4. Sobesky J, Zaro Weber O, Lehnhardt FG, et al. Which time-to-peak threshold best identifies penumbral flow? A comparison of perfusion-weighted magnetic resonance imaging and positron emission tomography in acute ischemic stroke. Stroke 2004; 35:2843-2847.
5. Shimosegawa E, Hatazawa J, Ibaraki M, et al. Metabolic penumbra of acute brain infarction: a correlation with infarct growth. Ann Neurol 2005; 57:495-504.
6. Guadagno JV, Jones PS, Fryer TD, et al. Local relationships between restricted water diffusion and oxygen consumption in the ischemic human brain. Stroke 2006; 37:1741-1748.
7. Guadagno JV, Warburton EA, Aigbirhio FI, et al. Does the acute diffusion-weighted imaging lesion represent penumbra as well as core? A combined quantitative PET/MRI voxel-based study. J Cereb Blood Flow Metab 2004; 24:1249-1254.
8. Guadagno JV, Warburton EA, Jones PS, et al. How affected is oxygen metabolism in DWI lesions? A combined acute stroke PET-MR study. Neurology 2006; 67:824-829. The authors demonstrate different degrees of metabolic disturbance in DWI lesions.
9. Hoehn-Berlage M, Norris DG, Kohno K, et al. Evolution of regional changes in apparent diffusion coefficient during focal ischemia of rat brain: the relationship of quantitative diffusion NMR imaging to reduction in cerebral blood flow and metabolic disturbances. JCereb BloodFlowMetab1995;15:1002-1011.
10. Lin W, Lee JM, Lee YZ, et al. Temporal relationship between apparent diffusion coefficient and absolute measurements of cerebral blood flow in acute stroke patients. Stroke 2003; 34:64-70.
11. Saur D, Buchert R, Knab R, et al. Iomazenil-single-photon emission computed tomography reveals selective neuronal loss in magnetic resonance-defined mismatch areas. Stroke 2006; 37:2713-2719.
12. Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 2003; 34:2729-2735.
13. Neumann-Haefelin T, Wittsack HJ, Wenserski F, et al. Diffusion- and perfusion-weighted MRI: the DWI/PWI mismatch region in acute stroke. Stroke 1999; 30:1591-1597.
14. Lee JM, Vo KD, An H, et al. Magnetic resonance cerebral metabolic rate of oxygen utilization in hyperacute stroke patients. Ann Neurol 2003; 53:227-232.
15. Geisler BS, Brandhoff F, Fiehler J, et al. Blood-oxygen-level- dependent MRI allows metabolic description of tissue at risk in acute stroke patients. Stroke 2006; 37:1778-1784.
16. Sun PZ, Zhou J, Sun W, et al. Detection of the ischemic penumbra using pH-weighted MRI. J Cereb Blood Flow Metab 2006; 29 November [Epub ahead of print].
17. Stengel A, Neumann-Haefelin T, Singer OC, et al. Multiple spin-echo spectroscopic imaging for rapid quantitative assessment of N-acetylaspartate and lactate in acute stroke. Magn Reson Med 2004; 52:228-238.
18. Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006; 60:508-517. The DEFUSE study is the first prospective study to evaluate response to thrombolysis depending on different MRI patterns. Only patients with mismatch showed benefit from reperfusion.
19. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005; 36:1432-1438.
20. Smith WS. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke: results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol 2006; 27:1177-1182.
21. Hacke W, Albers G, Al-Rawi Y, et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-h windowacute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005; 36:66-73.
22. Furlan AJ, Eyding D, Albers GW, et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 h after stroke onset. Stroke 2006; 37:1227-1231.
23. Davis S, Donnan G. EPITHET; 2006. http://www.strokecenter.org/trials. [Accessed 15 May 2007]
24. Kidwell CS. MR Rescue Trial; 2006. http://www.strokecenter.org/trials. [Accessed 15 May 2007]
25. Thomalla G, Schwark C, Sobesky J, et al. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 h in MRI- selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials. Stroke 2006; 37:852-858.
26. Köhrmann M, Juttler E, Fiebach JB, et al. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol 2006; 5:661-667.
27. Kane I, Sandercock P, Wardlaw J. Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date. J Neurol Neurosurg Psychiatry 2007; 78:485-491. This systematic literature review highlights still existing problems of the MRI mismatch concept.
28. Khatri P, Wechsler LR, Broderick JP. Intracranial hemorrhage associated with revascularization therapies. Stroke 2007; 38:431-440.
29. Tong DC, Adami A, Moseley ME, Marks MP. Relationship between apparent diffusion coefficient and subsequent hemorrhagic transformation following acute ischemic stroke. Stroke 2000; 31:2378-2384.
30. Selim M, Fink JN, Kumar S, et al. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke 2002; 33:2047-2052.
31. Alsop DC, Makovetskaya E, Kumar S, et al. Markedly reduced apparent blood volume on bolus contrast magnetic resonance imaging as a predictor of hemorrhage after thrombolytic therapy for acute ischemic stroke. Stroke 2005; 36: 746-750.
32. Fiehler J, Remmele C, Kucinski T, et al. Reperfusion after severe local perfusion deficit precedes hemorrhagic transformation: an MRI study in acute stroke patients. Cerebrovasc Dis 2005; 19:117-124.
33. Singer OC, Hoelig S, Humpich M, et al. Increasing size of the DWI lesion prior to thrombolysis promotes symptomatic hemorrhagic transformation. Stroke 2007; 38:454.
34. Dijkhuizen RM, Asahi M, Wu O, et al. Delayed rt-PA treatment in a rat embolic stroke model: diagnosis and prognosis of ischemic injury and hemorrhagic transformation with magnetic resonance imaging. J Cereb Blood Flow Metab 2001; 21:964-971.
35. Neumann-Haefelin C, Brinker G, Uhlenkuken U, et al. Prediction of hemorrhagic transformation after thrombolytic therapy of clot embolism: an MRI investigation in rat brain. Stroke 2002; 33:1392-1398.
36. KimEY, Na DG, KimSS, et al. Prediction of hemorrhagic transformation in acute ischemic stroke: role of diffusion-weighted imaging and early parenchymal enhancement. AJNR Am J Neuroradiol 2005; 26:1050-1055.
37. Kassner A, Roberts T, Taylor K, et al. Prediction of hemorrhage in acute ischemic stroke using permeability MR imaging. AJNR Am J Neuroradiol 2005; 26:2213-2217.
38. Latour LL, Kang DW, Ezzeddine MA, et al. Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol 2004; 56:468-477.
39. Neumann-Haefelin T, Hoelig S, Berkefeld J, et al. Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke 2006; 37:2463-2466. This is one of the largest MRI studies of patients treated with thrombolysis published so far and establishes preexisting small vessel disease as a risk factor for hemorrhagic transformation after thrombolysis.
40. Smith EE, Rosand J, Knudsen KA, et al. Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology 2002; 59: 193-197.
41. Kakuda W, Thijs VN, Lansberg MG, et al. Clinical importance of microbleeds in patients receiving IV thrombolysis. Neurology 2005; 65:1175-1178.
42. Fiehler J, Boulanger JM, Kakuda W, et al. Bleeding risk analysis in stroke by T2*-weighted imaging before thrombolysis (BRAZIL): a multicenter study of 600 patients of the MR Stroke Collaborative Group. Stroke 2006; 37:636.